Awards
Young Surgeons Award
The jury of the the Young Surgeons Award from the Austrian Society of Surgery could not be given to only one presenter. Proud to see the TELLVienna group beeing awarded this honor.
The jury of the the Young Surgeons Award from the Austrian Society of Surgery could not be given to only one presenter. Proud to see the TELLVienna group beeing awarded this honor.
Using our strength as a group to do something aside from research. For the Vienna city marathon we decided to run for a viennese organization that supports home care for children with cancer. With the support of several private donors we were able to collect 3000 Euros and certainly drew Read more…
Philipp just presented our first explorative data on systematic metabolomic analyses of patients samples at the German surgical congress – exciting new findings to better understand the process of liver regeneration in humans
Great to see 12 young people discussing and elaborating new ideas. After an exciting winter hike we spend 3 days of brainstorming and learning from each other – truly inspiring + great new ideas
David Pereyra received the best poster award at this years 11th EFR (european federation for colorectal cancer) congress with our work on Osteopontin and its association with disease recurrence after liver resection. TELLvienna congratulates to this great achievement! Great performance and well deserved!
ILC/EASL 2019 Excited to see major interest in our work @ILC2019, EASL in Vienna. Thank you @Medizin Medien Austria for featuring our results and surgical highlights of the congress with an interview – great pleasure. https://medonline.at/innere-medizin/onkologie/krebshilfe/easl-ilc/2019/10028197/easl-ilc-2019-leber-aus-dem-labor-und-weitere-highlights-fuer-chirurgen/
Ever found it puzzling that a patient with more than 12 months of neoadjuvant chemotherapy flies trough postoperative recovery after major liver resection without any signs of chemotherapy associated steatohepatitis (CASH) on histology, while some patients after only 2 months of systemic therapy struggle significantly due to chemotherapy associated liver Read more…
Remember your last patient developing liver failure after liver resection? Proofs of our recent work on miRNAs in liver surgery are out now demonstrating that miRNAs are sensitive markers for preoperative liver function and predict postoperative outcomes – freely available on: https://lnkd.in/dUq25YG A major step towards personalized medicine in HB Read more…
Ever found it puzzling that a patient with more than 12 months of neoadjuvant chemotherapy flies trough postoperative recovery after major liver resection without any signs of chemotherapy associated steatohepatitis (CASH) on histology, while some patients after only 2 months of systemic therapy struggle significantly due to chemotherapy associated liver Read more…